Koninklijke Philips N.V. (ETR:PHI1)
Germany · Delayed Price · Currency is EUR | Market Cap | 26.18B +13.3% |
| Revenue (ttm) | 17.76B -0.1% |
| Net Income | 957.00M +480.0% |
| EPS | 0.98 +450.8% |
| Shares Out | n/a |
| PE Ratio | 27.48 |
| Forward PE | 15.33 |
| Dividend | 0.85 (3.16%) |
| Ex-Dividend Date | May 14, 2026 |
| Volume | 964 |
| Open | 26.99 |
| Previous Close | 27.19 |
| Day's Range | 26.91 - 27.06 |
| 52-Week Range | 20.92 - 28.00 |
| Beta | 0.81 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 3, 2026 |
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as ... [Read more]
Financial Performance
Financial StatementsNews
Philips Avent Launches New Natural Response Glass Baby Bottle with a Lighter, Stronger Design
Redesigned with high-quality premium glass, the bottle is up to 20% lighter ¹ and offers 10x stronger performance against sudden hot and cold changes* CAMBRIDGE, Mass., Nov. 9, 2026 /PRNewswire/ -- Ph...
Philips price target raised to EUR 29 from EUR 26 at BofA
BofA analyst Julien Ouaddour raised the firm’s price target on Philips (PHG) to EUR 29 from EUR 26 and keeps a Neutral rating on the shares.
Philips: 3 Key Takeaways for Long-Term Investors
Hospitals are consolidating vendors, and Philips is pitching integrated platforms over lowest price, a shift that could define the next contract cycle.
Philips price target raised to EUR 27 from EUR 25 at RBC Capital
RBC Capital raised the firm’s price target on Philips (PHG) to EUR 27 from EUR 25 and keeps a Sector Perform rating on the shares.
What Koninklijke Philips (PHG) Said on Its Q3 Earnings Call
Koninklijke Philips NYSE: PHG reported third-quarter comparable sales growth of 3%, an 8% increase in equipment order intake and a 70-basis-point expansion in adjusted EBITA margin to 13%, as growth i...
Philips backs FY26 comparable sales growth view 3%-4.5%
Backs FY26 adjusted EBITDA margin view 13.5%-14%. Backs FY26 free cash flow view EUR 1.5B-EUR 1.7B. The company said, “Within the context of an uncertain macro-environment, Philips (PHG)’ 2026 outlook...
Koninklijke Philips Earnings Call Transcript: Q3 2026
Q3 order intake rose 8%, comparable sales grew 3%, and Adjusted EBITA margin expanded 70 bps to 13%. Full-year guidance was reiterated, with Personal Health growth outlook raised to the lower end of high single digits.
Koninklijke Philips Quarterly report: Q3 2026
Koninklijke Philips has published its Q3 2026 quarterly earnings report on November 3, 2026.
Koninklijke Philips Slides: Q3 2026
Koninklijke Philips has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
Philips Sales Rise Amid Product Recall Agreement
The Dutch health-technology company said it reached an agreement to resolve previous criminal and civil investigations related to product recalls in its respironics subsidiary.
Philips Q3 Profit Plunges, Adj. EBITDA Up; Backs FY26 Outlook
(RTTNews) - Dutch consumer electronics giant Koninklijke Philips N.V. (PHGFF.PK, PHG) reported Tuesday sharply lower profit in its third quarter, mainly hurt by Respironics DOJ settlement provision, w...
Philips beats quarterly profit estimates driven by higher sales, gross margin
Philips beats quarterly profit estimates driven by higher sales, gross margin
Philips delivers strong order intake growth, comparable sales growth and strong margin expansion in Q3; 2026 outlook reiterated
November 3, 2026 Q3 2026 Group performance Comparable order intake increased by 8%, driven by strong Diagnosis & Treatment Group sales of EUR 4.4 billion, reflecting 3% comparable sales growth Income ...
Philips announces commercial availability of HyperVue in the U.S.
Philips (PHG) announced U.S. commercial availability of the HyperVue Integrated System, a new single room-based configuration of its HyperVue Imaging System for DeepOCT+NIRS imaging and X1-FFR physiol...
Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab
New fixed, single-room configuration is designed to make DeepOCT+NIRS Imaging and X1-FFR physiology readily available for efficient cath lab workflows At TCT 2026, Philips will showcase its broader f...
Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform
October 29, 2026 New CE-marked solution leverages the industry-leading Philips Azurion platform to integrate CT-derived insights and treatment planning directly into the procedural workflow, helping p...
Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform
October 29, 2026 New CE-marked solution leverages the industry-leading Philips Azurion platform to integrate CT-derived insights and treatment planning directly into the procedural workflow, helping p...
Philips identifies three beauty tech trends set to transform beauty routines into lasting relationships by 2027
Leading beauty industry voices, Dr. Aamna Adel, UK Consultant Dermatologist and HCP influencer , Alice Crossley, Principal Strategic Foresight Analyst at The Future Laboratory , and Tiffany Buathier, ...
Gaming Has Become a Source of Real-World Style Inspiration. The Most Important Character That Gamers Are Customizing?
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA) – From character creation and custom skins to real-world cosplay fashion and streaming culture, gaming has its own visual langua...
Philips highlights Integrated Diagnostics' role in the future of cardiovascular informatics following MediReport acquisition
October 20, 2026 Advanced reporting and workflow capabilities developed by MediReport are expected to complement Philips' cardiovascular informatics portfolio and support its evolution toward a more c...
HeartBeam Joins Philips-Led EXIT-CVD Consortium For Cardiovascular Research In Europe; Stock Up
(RTTNews) - On Thursday, HeartBeam Inc. (BEAT), a medical technology company, announced its participation in EXIT-CVD, a five-year European research initiative led by Philips (PHG) and University Medi...
Philips launches five-year EXIT-CVD research project
Philips (PHG) announced the launch of the five-year EXIT-CVD research project, co-funded by the European Union Innovative Health Initiative, or IHI, and the industry partners. The research consortium ...
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
October 15, 2026 Five-year research project unites 42 public and private partners across 17 countries to conduct 22 clinical studies involving 14,000+ patients; first patients will be enrolled this mo...
Philips announces formation of Philips Sonicare Global Clinical Advisory Board
Royal Philips (PHG) announced the formation of the Philips Sonicare Global Clinical Advisory Board, a group of external oral healthcare experts established to help shape the future of Philips Oral…
Philips Oral Healthcare Establishes Global Clinical Advisory Board to Help Shape the Future of Oral Care Through Scientific and Clinical Insight
AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in oral healthcare, today announced the formation of the Philips Sonicare Global Clinical Advisory Board, a group of e...